Generic placeholder image

Anti-Cancer Agents in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1871-5206
ISSN (Online): 1875-5992

Review Article

Exploring Synthesis and Chemotherapeutic Potential of Thiosemicarbazide Analogs

Author(s): Akhalesh Kumar, Rakhi Mishra*, Avijit Mazumder, Rupa Mazumder and Shruti Varshney

Volume 23, Issue 1, 2023

Published on: 17 August, 2022

Page: [60 - 75] Pages: 16

DOI: 10.2174/1871520622666220603090626

Price: $65

Abstract

Background: Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. Researchers are continually finding new and more effective medications to battle the diseases.

Objective: The objective of this study is to identify the emerging role of Thiosemicarbazide analogs for different types of cancer targets with a glance at different novel synthetic routes reported for their synthesis.

Methods: A systematic literature review was conducted from various sources over the last 15 years with the inclusion of published research and review articles that involves the synthesis and use of thiosemicarbazide analogs for different targets of cancer. Data from the literature review for synthesis and anticancer potential for specific targets for cancer studies of thiosemicarbazide analogs are summarized in the paper.

Results: There are several emerging studies for new synthetic routes of thiosemicarbazide derivatives with their role in various types of cancers. The main limitation is the lack of clinical trial of the key findings for the emergence of new anticancer medication with thiosemicarbazide moiety.

Conclusion: Emerging therapies exist for use of a limited number of medications for the treatment of cancer; results of the ongoing studies will provide more robust evidence in the future.

Keywords: Thiosemicarbazide, cancer, target, synthesis, diseases, clinical trial.

Graphical Abstract

[1]
Ali, N.A.; O’Brien, J.M., Jr; Blum, W.; Byrd, J.C.; Klisovic, R.B.; Marcucci, G.; Phillips, G.; Marsh, C.B.; Lemeshow, S.; Grever, M.R. Hyperglycemia in patients with acute myeloid leukemia is associated with increased hospital mortality. Cancer, 2007, 110(1), 96-102.
[http://dx.doi.org/10.1002/cncr.22777] [PMID: 17534900]
[2]
Galanski, M.; Arion, V.B.; Jakupec, M.A.; Keppler, B.K. Recent developments in the field of tumor-inhibiting metal complexes. Curr. Pharm. Des., 2003, 9(25), 2078-2089.
[http://dx.doi.org/10.2174/1381612033454180] [PMID: 14529417]
[3]
Hill, J.M.; Speer, R.J. Organo-platinum complexes as antitumor agents (review). Anticancer Res., 1982, 2(3), 173-186.
[PMID: 6751211]
[4]
García-Valverde, M.; Torroba, T. Sulfur-nitrogen heterocycles. Molecules, 2005, 10(2), 318-320.
[http://dx.doi.org/10.3390/10020318]
[5]
Bhavsar, Z.A.; Acharya, P.T.; Jethava, D.J.; Patel, H.D. Recent advances in development of anthelmintic agents: Synthesis and biological screening. Synth. Commun., 2020, 50(7), 917-946.
[http://dx.doi.org/10.1080/00397911.2019.1695276]
[6]
Bhat, M.A.; Khan, A.A.; Ghabbour, H.A.; Quah, C.K.; Fun, H.K. Synthesis, characterization, x-ray structure and antimicrobial activity of N-(4-chlorophenyl)-2-(pyridin-4-ylcarbonyl) hydrazinecarbothioamide. Trop. J. Pharm. Res., 2016, 15(8), 1751-1757.
[http://dx.doi.org/10.4314/tjpr.v15i8.22]
[7]
Beraldo, H.; Gambino, D. The wide pharmacological versatility of semicarbazones, thiosemicarba-zones and their metal complexes. Mini Rev. Med. Chem., 2004, 4(1), 31-39.
[http://dx.doi.org/10.2174/1389557043487484] [PMID: 14754441]
[8]
Sardari, S.; Feizi, S.; Rezayan, A.H.; Azerang, P.; Shahcheragh, S.M.; Ghavami, G.; Habibi, A. Synthesis and biological evaluation of thiosemicarbazide derivatives endowed with high activity toward Mycobacterium bovis. Iran. J. Pharm. Res., 2017, 16(3), 1128-1140.
[PMID: 29201099]
[9]
Metwally, M.A.; Bondock, S.; El-Azap, H.; Kandeel, E.E. Thiosemicarbazides: Synthesis and reactions. J. Sulfur Chem., 2011, 32(5), 489-519.
[http://dx.doi.org/10.1080/17415993.2011.601869]
[10]
Mustafa, S.M.; Nair, V.A.; Chittoor, J.P.; Krishnapillai, S. Synthesis of 1, 2, 4-triazoles and thiazoles from thiosemicarbazide and its derivatives. Mini Rev. Org. Chem., 2004, 1(4), 375-385.
[http://dx.doi.org/10.2174/1570193043403082]
[11]
Gou, Y. Wang, J.; Chen, S.; Zhang, Z.; Zhang, Y.; Zhang, W.; Yang, F. α-N-heterocyclic thiosemicarbazone Fe(III) complex: Characterization of its antitumor activity and identification of anticancer mechanism. Eur. J. Med. Chem., 2016, 123, 354-364.
[http://dx.doi.org/10.1016/j.ejmech.2016.07.041] [PMID: 27487566]
[12]
Bisceglie, F.; Tavone, M.; Mussi, F.; Azzoni, S.; Montalbano, S.; Franzoni, S.; Tarasconi, P.; Buschini, A.; Pelosi, G. Effects of polar substituents on the biological activity of thiosemicarbazone metal complexes. J. Inorg. Biochem., 2018, 179, 60-70.
[http://dx.doi.org/10.1016/j.jinorgbio.2017.11.009] [PMID: 29175629]
[13]
Huang, H.; Chen, Q.; Ku, X.; Meng, L.; Lin, L.; Wang, X.; Zhu, C.; Wang, Y.; Chen, Z.; Li, M.; Jiang, H.; Chen, K.; Ding, J.; Liu, H. A series of α-heterocyclic carboxaldehyde thiosemicarbazones inhibit topoisomerase IIalpha catalytic activity. J. Med. Chem., 2010, 53(8), 3048-3064.
[http://dx.doi.org/10.1021/jm9014394] [PMID: 20353152]
[14]
Xie, W.; Xie, S.; Zhou, Y.; Tang, X.; Liu, J.; Yang, W.; Qiu, M. Design and synthesis of novel 5,6-disubstituted pyridine-2,3-dione-3-thiosemicarbazone derivatives as potential anticancer agents. Eur. J. Med. Chem., 2014, 81, 22-27.
[http://dx.doi.org/10.1016/j.ejmech.2014.05.001] [PMID: 24819956]
[15]
Lui, G.Y.; Kovacevic, Z.V.; Menezes, S.; Kalinowski, D.S.; Merlot, A.M.; Sahni, S.; Richardson, D.R. Novel thiosemicarbazones regulate the signal transducer and activator of transcription 3 (STAT3) pathway: Inhibition of constitutive and interleukin 6-induced activation by iron depletion. Mol. Pharmacol., 2015, 87(3), 543-560.
[http://dx.doi.org/10.1124/mol.114.096529] [PMID: 25561562]
[16]
Feun, L.; Modiano, M.; Lee, K.; Mao, J.; Marini, A.; Savaraj, N.; Plezia, P.; Almassian, B.; Colacino, E.; Fischer, J.; MacDonald, S. Phase I and pharmacokinetic study of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) using a single intravenous dose schedule. Cancer Chemother. Pharmacol., 2002, 50(3), 223-229.
[http://dx.doi.org/10.1007/s00280-002-0480-0] [PMID: 12203104]
[17]
Mackenzie, M.J.; Saltman, D.; Hirte, H.; Low, J.; Johnson, C.; Pond, G.; Moore, M.J. A Phase II study of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) and gemcitabine in advanced pancreatic carcinoma. A trial of the Princess Margaret hospital Phase II consortium. Invest. New Drugs, 2007, 25(6), 553-558.
[http://dx.doi.org/10.1007/s10637-007-9066-3] [PMID: 17585372]
[18]
Yu, Y.; Rahmanto, Y.S.; Hawkins, C.L.; Richardson, D.R. The potent and novel thiosemicarbazone chelators, Dp44mT and Bp44mT, affect crucial thiol systems required for ribonucleotide reductase activity. Mol. Pharmacol., 2011, 1, 1-34.
[19]
Rao, V.A.; Klein, S.R.; Agama, K.K.; Toyoda, E.; Adachi, N.; Pommier, Y.; Shacter, E.B. The iron chelator Dp44mT causes DNA damage and selective inhibition of topoisomerase IIalpha in breast cancer cells. Cancer Res., 2009, 69(3), 948-957.
[http://dx.doi.org/10.1158/0008-5472.CAN-08-1437] [PMID: 19176392]
[20]
Malarz, K.; Mrozek-Wilczkiewicz, A.; Serda, M.; Rejmund, M.; Polanski, J.; Musiol, R. The role of oxidative stress in activity of anticancer thiosemicarbazones. Oncotarget, 2018, 9(25), 17689-17710.
[http://dx.doi.org/10.18632/oncotarget.24844] [PMID: 29707141]
[21]
Rejmund, M.; Mrozek-Wilczkiewicz, A.; Malarz, K.; Pyrkosz-Bulska, M.; Gajcy, K.; Sajewicz, M.; Musiol, R.; Polanski, J. Piperazinyl fragment improves anticancer activity of Triapine. PLoS One, 2018, 13(4), e0188767.
[http://dx.doi.org/10.1371/journal.pone.0188767] [PMID: 29652894]
[22]
Whitnall, M.; Howard, J.; Ponka, P.; Richardson, D.R. A class of iron chelators with a broad spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics. Proc. Natl. Acad. Sci, 2006, 103(40), 14901-14906.
[http://dx.doi.org/10.1073/pnas.0604979103] [PMID: 17003122]
[23]
Sharma, V.K.; Srivastava, S. Synthesis, magnetic and spectral studies of chromium (III), manganese (III), iron (III) and cobalt (III) complexes of thiosemicarbazones derived from benzil α-monoxime and unsubstituted/substituted thiosemicarbazides as biological agents. J. Coord. Chem., 2008, 61(2), 178-191.
[http://dx.doi.org/10.1080/00958970701318426]
[24]
Thanh, N.D.; Giang, N.T.K.; Quyen, T.H.; Huong, D.T.; Toan, V.N. Synthesis and evaluation of in vivo antioxidant, in vitro antibacterial, MRSA and antifungal activity of novel substituted isatin N-(2,3,4,6-tetra-O-acetyl-β-d-glucopyranosyl)thiosemicarbazones. Eur. J. Med. Chem., 2016, 123, 532-543.
[http://dx.doi.org/10.1016/j.ejmech.2016.07.074] [PMID: 27517802]
[25]
Abou-Melha, K.S. Octahedral Co (II) and Ni (II) complexes of schiff bases, semicarbazone and thiosemicarbazone, synthesis, biological, spectral, and thermal studies. J. Coord. Chem., 2008, 61(13), 2053-2067.
[http://dx.doi.org/10.1080/00958970701862167]
[26]
Trotsko, N.; Kosikowska, U.; Paneth, A.; Plech, T.; Malm, A.; Wujec, M. Synthesis and antibacterial activity of new thiazolidine-2, 4-dione-based chlorophenylthiosemicarbazone hybrids. Molecules, 2018, 23(5), 1023.
[http://dx.doi.org/10.3390/molecules23051023] [PMID: 29701728]
[27]
Paneth, A. Stączek, P.; Plech, T.; Strzelczyk, A.; Dzitko, K.; Wujec, M.; Kuśmierz, E.; Kosikowska, U.; Grzegorczyk, A.; Paneth, P. Biological evaluation and molecular modelling study of thiosemicarbazide derivatives as bacterial type IIA topoisomerases inhibitors. J. Enzyme Inhib. Med. Chem., 2016, 31(1), 14-22.
[http://dx.doi.org/10.3109/14756366.2014.1003214] [PMID: 25792505]
[28]
Batista, S.A.; Vandresen, F.; Falzirolli, H.; Britta, E.; de Oliveira, D.N.; Catharino, R.R.; Gonçalves, M.A.; Ramalho, T.C.; La Porta, F.A.; Nakamura, C.V.; da Silva, C.C. Synthesis and comparison of antileishmanial and cytotoxic activities of S- (−)-limonene benzaldehydethiosemicarbazones with their R-(+)-analogues. J. Mol. Struct., 2019, 1179, 252-262.
[http://dx.doi.org/10.1016/j.molstruc.2018.11.017]
[29]
Patel, S.R.; Gangwal, R.; Sangamwar, A.T.; Jain, R. Synthesis, biological evaluation and 3D-QSAR study of hydrazide, semicarbazide and thiosemicarbazide derivatives of 4-(adamantan-1-yl)quinoline as anti-tuberculosis agents. Eur. J. Med. Chem., 2014, 85, 255-267.
[http://dx.doi.org/10.1016/j.ejmech.2014.07.100] [PMID: 25089809]
[30]
Ratsimamanga; Buu-Hoi, N.P.; Dechamps, G.; Bihan, H.L.; Binon, F.; Nigeon-Dureuil, The in vivo antitubercular activity of some thiosemicarbazide derivatives. C. R. Seances Soc. Biol. Fil., 1952, 146(5-6), 354-357.
[PMID: 12988415]
[31]
Haraguchi, S.K.; Silva, A.A.; Vidotti, G.J.; dos Santos, P.V.; Garcia, F.P.; Pedroso, R.B.; Nakamura, C.V.; de Oliveira, C.M.; da Silva, C.C. Antitrypanasomal activity of novel benzaldehyde-thiosemicarbazone derivatives from kaurenoic acid. Molecules, 2011, 16(2), 1166-1180.
[http://dx.doi.org/10.3390/molecules16021166] [PMID: 21270733]
[32]
Paterson, B.M.; Donnelly, P.S. Copper complexes of bis(thiosemicarbazones): From chemotherapeutics to diagnostic and therapeutic radiopharmaceuticals. Chem. Soc. Rev., 2011, 40(5), 3005-3018.
[http://dx.doi.org/10.1039/c0cs00215a] [PMID: 21409228]
[33]
Subhashree, G.R.; Haribabu, J.; Saranya, S.; Yuvaraj, P.; Krishnan, D.A.; Karvembu, R.; Gayathri, D. In vitro antioxidant, antiinflammatory and in silico molecular docking studies of thiosemicarbazones. J. Mol. Struct., 2017, 1145, 160-169.
[http://dx.doi.org/10.1016/j.molstruc.2017.05.054]
[34]
Islam, M.; Khan, A.; Shehzad, M.T.; Hameed, A.; Ahmed, N.; Halim, S.A.; Khiat, M.; Anwar, M.U.; Hussain, J.; Csuk, R.; Shafiq, Z.; Al-Harrasi, A. Synthesis and characterization of new thiosemicarbazones, as potent urease inhibitors: in vitro and in silico studies. Bioorg. Chem., 2019, 87, 155-162.
[http://dx.doi.org/10.1016/j.bioorg.2019.03.008] [PMID: 30884309]
[35]
Hameed, A.; Khan, K.M.; Zehra, S.T.; Ahmed, R.; Shafiq, Z.; Bakht, S.M.; Yaqub, M.; Hussain, M.; de la Vega de León, A.; Furtmann, N.; Bajorath, J.; Shad, H.A.; Tahir, M.N.; Iqbal, J. Synthesis, biological evaluation and molecular docking of N-phenyl thiosemicarbazones as urease inhibitors. Bioorg. Chem., 2015, 61, 51-57.
[http://dx.doi.org/10.1016/j.bioorg.2015.06.004] [PMID: 26119990]
[36]
Kumar, V.A.; Sarala, Y.; Siddikha, A.; Vanitha, S.; Babu, S.; Reddy, A.V. Synthesis, characterization antimicrobial and antioxidant activities of 2, 4-dihydroxybenzaldehyde-4-phenyl-3-thiosemicarbazone (DHBPTSC) and its Pd (II), Ni (II) dppm Mixed ligand and Cu (II) complex having heterocyclic bases. J. Appl. Pharm. Sci., 2018, 8(04), 071-8.
[37]
Nguyen, D.T.; Le, T.H.; Bui, T.T. Antioxidant activities of thiosemicarbazones from substituted benzaldehydes and N-(tetra-O-acetyl-β-D-galactopyranosyl)thiosemicarbazide. Eur. J. Med. Chem., 2013, 60, 199-207.
[http://dx.doi.org/10.1016/j.ejmech.2012.10.004] [PMID: 23291121]
[38]
Namiecińska, E.; Sobiesiak, M.; Małecka, M.; Guga, P.; Rozalska, B.; Budzisz, E. Antimicrobial and structural properties of metal ions complexes with thiosemicarbazide motif and related heterocyclic compounds. Curr. Med. Chem., 2019, 26(4), 664-693.
[http://dx.doi.org/10.2174/0929867325666180228164656] [PMID: 29493443]
[39]
Sroor, F.M.; Khatab, T.K.; Basyouni, W.M.; El-Bayouki, K.A. Synthesis and molecular docking studies of some new thiosemicarbazone derivatives as HCV polymeraseinhibitors. Synth. Commun., 2019, 49(11), 1444-1456.
[http://dx.doi.org/10.1080/00397911.2019.1605443]
[40]
Kozyra, P.; Korga-Plewko, A.; Karczmarzyk, Z. Hawrył A.; Wysocki, W.; Człapski, M.; Iwan, M.; Ostrowska-Leśko, M.; Fornal, E.; Pitucha, M. Potential anticancer agents against melanoma cells based on an as-synthesized thiosemicarbazide derivative. Biomolecules, 2022, 12(2), 151.
[http://dx.doi.org/10.3390/biom12020151] [PMID: 35204651]
[41]
Serda, M.; Kalinowski, D.S.; Rasko, N. Potůčková, E.; Mrozek-Wilczkiewicz, A.; Musiol, R.; Małecki, J.G.; Sajewicz, M.; Ratuszna, A.; Muchowicz, A.; Gołąb, J.; Simůnek, T.; Richardson, D.R.; Polanski, J. Exploring the anti-cancer activity of novel thiosemicarbazones generated through the combination of retro-fragments: Dissection of critical structure-activity relationships. PLoS One, 2014, 9(10), e110291.
[http://dx.doi.org/10.1371/journal.pone.0110291] [PMID: 25329549]
[42]
Kshirsagar, A.; Toraskar, M.P.; Kulkarni, V.M.; Dhanashire, S.; Kadam, V. Microwave assisted synthesis of potential anti-infective and anticonvulsant thiosemicarbazones. Int. J. Chemtech Res., 2009, 1(3), 696-701.
[43]
Yogeeswari, P.; Sriram, D.; Mehta, S.; Nigam, D.; Kumar, M.M.; Murugesan, S.; Stables, J.P. Anticonvulsant and neurotoxicity evaluation of some 6-substituted benzothiazolyl-2-thiosemicarbazones. Farmaco, 2005, 60(1), 1-5.
[http://dx.doi.org/10.1016/j.farmac.2004.09.001] [PMID: 15652361]
[44]
Liu, J.; Yi, W.; Wan, Y.; Ma, L.; Song, H. 1-(1-Arylethylidene)thiosemicarbazide derivatives: A new class of tyrosinase inhibitors. Bioorg. Med. Chem., 2008, 16(3), 1096-1102.
[http://dx.doi.org/10.1016/j.bmc.2007.10.102] [PMID: 18326070]
[45]
Ishaq, M.; Taslimi, P.; Shafiq, Z.; Khan, S.; Ekhteiari Salmas, R.; Zangeneh, M.M.; Saeed, A.; Zangeneh, A.; Sadeghian, N.; Asari, A.; Mohamad, H. Synthesis, bioactivity and binding energy calculations of novel 3-ethoxysalicylaldehyde based thiosemicarbazone derivatives. Bioorg. Chem., 2020, 100, 103924.
[http://dx.doi.org/10.1016/j.bioorg.2020.103924] [PMID: 32442818]
[46]
Grzegorzewicz, A.E.; Korduláková, J.; Jones, V.; Born, S.E.; Belardinelli, J.M.; Vaquié, A.; Gundi, V.A.; Madacki, J.; Slama, N.; Laval, F.; Vaubourgeix, J.; Crew, R.M.; Gicquel, B.; Daffé, M.; Morbidoni, H.R.; Brennan, P.J.; Quémard, A.; McNeil, M.R.; Jackson, M. A common mechanism of inhibition of the Mycobacterium tuberculosis mycolic acid biosynthetic pathway by isoxyl and thiacetazone. J. Biol. Chem., 2012, 287(46), 38434-38441.
[http://dx.doi.org/10.1074/jbc.M112.400994] [PMID: 23002234]
[47]
Grzegorzewicz, A.E.; Eynard, N.; Quémard, A.; North, E.J.; Margolis, A.; Lindenberger, J.J.; Jones, V.; Korduláková, J.; Brennan, P.J.; Lee, R.E.; Ronning, D.R.; McNeil, M.R.; Jackson, M. Covalent modification of the Mycobacterium tuberculosis FAS-II dehydratase by Isoxyl and Thiacetazone. ACS Infect. Dis., 2015, 1(2), 91-97.
[http://dx.doi.org/10.1021/id500032q] [PMID: 25897434]
[48]
Cihan-Üstündağ G.; Gürsoy, E.; Naesens, L.; Ulusoy-Güzeldemirci, N.; Çapan, G. Synthesis and antiviral properties of novel indole-based thiosemicarbazides and 4-thiazolidinones. Bioorg. Med. Chem., 2016, 24(2), 240-246.
[http://dx.doi.org/10.1016/j.bmc.2015.12.008] [PMID: 26707844]
[49]
Tsimberidou, A.M.; Alvarado, Y.; Giles, F.J. Evolving role of ribonucleoside reductase inhibitors in hematologic malignancies. Expert Rev. Anticancer Ther., 2002, 2(4), 437-448.
[http://dx.doi.org/10.1586/14737140.2.4.437] [PMID: 12647987]
[50]
Hernández, W.; Carrasco, F.; Vaisberg, A.; Spodine, E.; Manzur, J.; Icker, M.; Krautscheid, H.; Beyer, L. Synthesis, spectroscopic characterization, structural studies, and in vitro antitumor activities of pyridine-3-carbaldehyde thiosemicarbazone derivatives. J. Chem., 2020, 2020
[http://dx.doi.org/10.1155/2020/2960165]
[51]
Sibuh, B.Z.; Taneja, P.; Khanna, S. Effects of substituents on anticancer activity of thiosemicarbazone against MCF-7 human breast cancer cell line. bioRxiv, 2020.
[http://dx.doi.org/10.1101/2020.02.19.955690]
[52]
Yousef, T.A.; El-Reash, G.A. Synthesis, and biological evaluation of complexes based on thiosemicarbazone ligand. J. Mol. Struct., 2020, 1201, 127180.
[http://dx.doi.org/10.1016/j.molstruc.2019.127180]
[53]
Khan, T.; Dixit, S.; Ahmad, R.; Raza, S.; Azad, I.; Joshi, S.; Khan, A.R. Molecular docking, PASS analysis, bioactivity score prediction, synthesis, characterization and biological activity evaluation of a functionalized 2-butanone thiosemicarbazone ligand and its complexes. J. Chem. Biol., 2017, 10(3), 91-104.
[http://dx.doi.org/10.1007/s12154-017-0167-y] [PMID: 28684996]
[54]
Abhale, Y.K.; Shinde, A.; Deshmukh, K.K.; Nawale, L.; Sarkar, D.; Mhaske, P.C. Synthesis, antitubercular and antimicrobial potential of some new thiazole substituted thiosemicarbazide derivatives. Med. Chem. Res., 2017, 26(10), 2557-2567.
[http://dx.doi.org/10.1007/s00044-017-1955-1]
[55]
Altintop, M.D.; Sever, B.; Özdemir, A. Kuş G.; Oztopcu-Vatan, P.; Kabadere, S.; Kaplancikli, Z.A. Synthesis and evaluation of naphthalene-based thiosemicarbazone derivatives as new anticancer agents against LNCaP prostate cancer cells. J. Enzyme Inhib. Med. Chem., 2016, 31(3), 410-416.
[PMID: 25826149]
[56]
Altıntop, M.D.; Atlı Ö.; Ilgın, S.; Demirel, R.; Özdemir, A.; Kaplancıklı Z.A. Synthesis and biological evaluation of new naphthalene substituted thiosemicarbazone derivatives as potent antifungal and anticancer agents. Eur. J. Med. Chem., 2016, 108, 406-414.
[http://dx.doi.org/10.1016/j.ejmech.2015.11.041] [PMID: 26706351]
[57]
Salib, S.B. Synthesis and antitumor activity of novel thienopyrimidine derivatives containing thiosemicarbazide moiety. Open Access Library J., 2016, 3(07), 1.
[http://dx.doi.org/10.4236/oalib.1102876]
[58]
Pitucha, M. Woś M.; Miazga-Karska, M.; Klimek, K.; Mirosław, B.; Pachuta-Stec, A.; Gładysz, A.; Ginalska, G. Synthesis, antibacterial and antiproliferative potential of some new 1-pyridinecarbonyl-4-substituted thiosemicarbazide derivatives. Med. Chem. Res., 2016, 25(8), 1666-1677.
[http://dx.doi.org/10.1007/s00044-016-1599-6] [PMID: 27499604]
[59]
Al-Mutairi, A.A.; Al-Alshaikh, M.A.; Al-Omary, F.A.M.; Hassan, H.M.; El-Mahdy, A.M.; El-Emam, A.A. Synthesis, antimicrobial, and antiproliferative activities of novel 4-(adamantan-1-yl)-1-arylidene-3-thiosemicarbazides, 4-arylmethyl N′-(Adamantan-1-yl) piperidine-1-carbothioimidates, and related derivatives. Molecules, 2019, 24(23), 4308.
[http://dx.doi.org/10.3390/molecules24234308] [PMID: 31779091]
[60]
Dadaş Y.; Coşkun, G.P.; Bingöl-Akpinar, O.; Ozsavci, D.; Küçükgüzel, S.G. Synthesis and anticancer activity of some novel tolmetin thiosemicarbazides. Marmara Pharm. J., 2015, 19, 259-267.
[http://dx.doi.org/10.12991/mpj.201519328306]
[61]
de Almeida, S.M.; Lafayette, E.A.; da Silva, L.P.; Amorim, C.A.; de Oliveira, T.B.; Ruiz, A.L.; de Carvalho, J.E.; de Moura, R.O.; Beltrão, E.I. de Lima, Mdo.C.; de Carvalho Júnior, L.B. Synthesis, DNA binding, and antiproliferative activity of novel acridine-thiosemicarbazone derivatives. Int. J. Mol. Sci., 2015, 16(6), 13023-13042.
[http://dx.doi.org/10.3390/ijms160613023] [PMID: 26068233]
[62]
Taşdemir, D.; Karaküçük-İyidoğan, A.; Ulaşli, M.; Taşkin-Tok, T.; Oruç-Emre, E.E.; Bayram, H. Synthesis, molecular modeling, and biological evaluation of novel chiral thiosemicarbazone derivatives as potent anticancer agents. Chirality, 2015, 27(2), 177-188.
[http://dx.doi.org/10.1002/chir.22408] [PMID: 25399965]
[63]
Gan, C.; Cui, J.; Su, S.; Lin, Q.; Jia, L.; Fan, L.; Huang, Y. Synthesis and antiproliferative activity of some steroidal thiosemicarbazones, semicarbazones and hydrozones. Steroids, 2014, 87, 99-107.
[http://dx.doi.org/10.1016/j.steroids.2014.05.026] [PMID: 24928726]
[64]
Nammalwar, B.; Bunce, R.A.; Berlin, K.D.; Benbrook, D.M.; Toal, C. Synthesis and biological evaluation of SHetA2 (NSC-721689) analogs against the ovarian cancer cell line A2780. Eur. J. Med. Chem., 2019, 170, 16-27.
[http://dx.doi.org/10.1016/j.ejmech.2019.03.010] [PMID: 30878829]
[65]
Abdelhafez, O.M.; Ahmed, E.Y.; Abdel Latif, N.A.; Arafa, R.K.; Abd Elmageed, Z.Y.; Ali, H.I. Design and molecular modeling of novel P38α MAPK inhibitors targeting breast cancer, synthesized from oxygen heterocyclic natural compounds. Bioorg. Med. Chem., 2019, 27(7), 1308-1319.
[http://dx.doi.org/10.1016/j.bmc.2019.02.027] [PMID: 30792101]
[66]
Han, I.M.; Tunc, C.U.; Atalay, P.; Erdogan, O.; Unal, G.; Bozkurt, M.; Aydin, O.; Cevik, O.; Kucukguzel, S.G. Design, synthesis, and in vitro and in vivo anticancer activity studies of new (S)-Naproxen thiosemicarbazide/1,2,4-triazole derivatives. New J. Chem., 2022, 46, 6046-6059.
[http://dx.doi.org/10.1039/D1NJ05899A]
[67]
Carcelli, M.; Tegoni, M.; Bartoli, J.; Marzano, C.; Pelosi, G.; Salvalaio, M.; Rogolino, D.; Gandin, V. In vitro and in vivo anticancer activity of tridentate thiosemicarbazone copper complexes: Unravelling an unexplored pharmacological target. Eur. J. Med. Chem., 2020, 194, 112266.
[http://dx.doi.org/10.1016/j.ejmech.2020.112266] [PMID: 32248006]
[68]
Saranya, S.; Haribabu, J.; Palakkeezhillam, V.N.; Jerome, P.; Gomathi, K.; Rao, K.K.; Babu, V.H.; Karvembu, R.; Gayathri, D. Molecular structures, Hirshfeld analysis and biological investigations of isatin based thiosemicarbazones. J. Mol. Struct., 2019, 1198, 126904.
[http://dx.doi.org/10.1016/j.molstruc.2019.126904]
[69]
Reddy, A.S.; Mao, J.; Krishna, L.S.; Badavath, V.N.; Maji, S. Synthesis, spectral investigation, molecular docking and biological evaluation of Cu (II), Ni (II) and Mn (II) complexes of (E)-2-((2-butyl-4-chloro-1H-imidazol-5-yl) methylene)-N-methylhydrazinecarbothioamide (C10H16N5ClS) and its DFT studies. J. Mol. Struct., 2019, 1196, 338-347.
[http://dx.doi.org/10.1016/j.molstruc.2019.06.085]
[70]
Haribabu, J.; Sabapathi, G.; Tamizh, M.M.; Balachandran, C.; Bhuvanesh, N.S.; Venuvanalingam, P.; Karvembu, R. Water-soluble mono-and binuclear Ru (η6-p-cymene) complexes containing indolethiosemicarbazones: Synthesis, DFT modeling, biomolecular interactions, and in vitro anticancer activity through apoptosis. Organometallics, 2018, 37(8), 1242-1257.
[http://dx.doi.org/10.1021/acs.organomet.8b00004]
[71]
Malki, A.; Elbayaa, R.Y.; Ashour, H.M.; Loffredo, C.A.; Youssef, A.M. Novel thiosemicarbazides induced apoptosis in human MCF-7 breast cancer cells via JNK signaling. J. Enzyme Inhib. Med. Chem., 2015, 30(5), 786-795.
[http://dx.doi.org/10.3109/14756366.2014.971781] [PMID: 25363687]
[72]
Farghaly, T.A.; El-Metwaly, N.; Al-Soliemy, A.M.; Katouah, H.A.; Muhammad, Z.A.; Sabour, R. Synthesis, molecular docking and antitumor activity of new dithiazoles. Polycycl. Aromat. Compd., 2019, 1-7.
[73]
Ertas, M.; Sahin, Z.; Bulbul, E.F.; Bender, C.; Biltekin, S.N.; Berk, B.; Yurttas, L.; Nalbur, A.M.; Celik, H. Demirayak, Ş Potent ribonucleotide reductase inhibitors: Thiazole-containing thiosemicarbazone derivatives. Arch. Pharm. (Weinheim), 2019, 352(11), e1900033.
[http://dx.doi.org/10.1002/ardp.201900033] [PMID: 31475759]
[74]
Divar, M.; Khalafi-Nezhad, A.; Zomorodian, K.; Sabet, R.; Faghih, Z.; Jamali, M.; Pournaghz, H.; Khabnadideh, S. Synthesis of some novel semicarbazone and thiosemicarbazone derivatives of isatin as possible biologically active agents. J. Pharm. Res. Int., 2017, 1-3.
[http://dx.doi.org/10.9734/JPRI/2017/35243]
[75]
Hmood, K.S.; Kubba, A.A.; Al-bayati, R.I.; Saleh, A.M. Synthesis, and anti-tumor evaluation of some new flurbiprofen derivatives against MCF-7 and WRL-68 cell lines. Indones. J. Pharm., 2021, 32(1), 17-34.
[76]
de Oliveira, J.F.; da Silva, A.L.; Vendramini-Costa, D.B.; da Cruz Amorim, C.A.; Campos, J.F.; Ribeiro, A.G.; Olímpio de Moura, R.; Neves, J.L.; Ruiz, A.L.; Ernesto de Carvalho, J. Alves de Lima, Mdo.C. Synthesis of thiophene-thiosemicarbazone derivatives and evaluation of their in vitro and in vivo antitumor activities. Eur. J. Med. Chem., 2015, 104, 148-156.
[http://dx.doi.org/10.1016/j.ejmech.2015.09.036] [PMID: 26454648]
[77]
Dincel, E.D.; Guzeldemirci, N.U. Synthesis and computer-aided drug design studies of novel thiosemicarbazide derivatives as potent and target-oriented anticancer agents. Medicine (Baltimore), 2020, 9(2), 305-313.
[78]
Khalil, O.M.; Gedawy, E.M.; El-Malah, A.A.; Adly, M.E. Novel nalidixic acid derivatives targeting topoisomerase II enzyme; Design, synthesis, anticancer activity and effect on cell cycle profile. Bioorg. Chem., 2019, 83, 262-276.
[http://dx.doi.org/10.1016/j.bioorg.2018.10.058] [PMID: 30391699]
[79]
Abdelaziz, O.A.; El Husseiny, W.M.; Selim, K.B.; Eisa, H.M. Dihydrofolate reductase inhibition effect of 5-substituted pyrido[2,3-d]pyrimidines: Synthesis, antitumor activity and molecular modeling study. Bioorg. Chem., 2019, 90, 103076.
[http://dx.doi.org/10.1016/j.bioorg.2019.103076] [PMID: 31260878]
[80]
Hekal, M.H.; Abu El-Azm, F.S.; Atta-Allah, S.R. Ecofriendly and highly efficient microwave-induced synthesis of novel quinazolinone-undecyl hybrids with in vitro antitumor activity. Synth. Commun., 2019, 49(20), 2630-2641.
[http://dx.doi.org/10.1080/00397911.2019.1637001]
[81]
Ribeiro, A.G.; Almeida, S.M.V.; de Oliveira, J.F.; Souza, T.R.C.L.; Santos, K.L.D.; Albuquerque, A.P.B.; Nogueira, M.C.B.L.; Carvalho, Junior, L.B.; Moura, R.O.; da Silva, A.C.; Pereira, V.R.A.; Castro, M.C.A.B.; Lima, M.D.C.A. Novel 4-quinoline-thiosemicarbazone derivatives: Synthesis, antiproliferative activity, in vitro and in silico biomacromolecule interaction studies and topoisomerase inhibition. Eur. J. Med. Chem., 2019, 182, 111592.
[http://dx.doi.org/10.1016/j.ejmech.2019.111592] [PMID: 31421632]
[82]
Bakherad, Z.; Safavi, M.; Fassihi, A.; Sadeghi-Aliabadi, H.; Bakherad, M.; Rastegar, H.; Saeedi, M.; Ghasemi, J.B.; Saghaie, L.; Mahdavi, M. Design and synthesis of novel cytotoxic indole-thiosemicarbazone derivatives: biological evaluation and docking study. Chem. Biodivers., 2019, 16(4), e1800470.
[http://dx.doi.org/10.1002/cbdv.201800470] [PMID: 30845369]
[83]
Geng, P.F.; Liu, X.Q.; Zhao, T.Q.; Wang, C.C.; Li, Z.H.; Zhang, J.; Wei, H.M.; Hu, B.; Ma, L.Y.; Liu, H.M. Design, synthesis and in vitro biological evaluation of novel [1,2,3]triazolo[4,5-d]pyrimidine derivatives containing a thiosemicarbazide moiety. Eur. J. Med. Chem., 2018, 146, 147-156.
[http://dx.doi.org/10.1016/j.ejmech.2018.01.031] [PMID: 29407946]
[84]
Gaber, A.A.; Bayoumi, A.H.; El-Morsy, A.M.; Sherbiny, F.F.; Mehany, A.B.M.; Eissa, I.H. Design, synthesis and anticancer evaluation of 1H-pyrazolo[3,4-d]pyrimidine derivatives as potent EGFRWT and EGFRT790M inhibitors and apoptosis inducers. Bioorg. Chem., 2018, 80, 375-395.
[http://dx.doi.org/10.1016/j.bioorg.2018.06.017] [PMID: 29986185]
[85]
Wos, M.; Miazga-Karska, M.; Kaczor, A.A.; Klimek, K.; Karczmarzyk, Z.; Kowalczuk, D.; Wysocki, W.; Ginalska, G.; Urbanczyk-Lipkowska, Z.; Morawiak, M.; Pitucha, M. Novel thiosemicarbazide derivatives with 4-nitrophenyl group as multi-target drugs: Α-glucosidase inhibitors with antibacterial and antiproliferative activity. Biomed. Pharmacother., 2017, 93, 1269-1276.
[http://dx.doi.org/10.1016/j.biopha.2017.07.049] [PMID: 28747001]
[86]
Wang, Y.; Gu, W.; Shan, Y.; Liu, F.; Xu, X.; Yang, Y.; Zhang, Q.; Zhang, Y.; Kuang, H.; Wang, Z.; Wang, S. Design, synthesis and anticancer activity of novel nopinone-based thiosemicarbazone derivatives. Bioorg. Med. Chem. Lett., 2017, 27(11), 2360-2363.
[http://dx.doi.org/10.1016/j.bmcl.2017.04.024] [PMID: 28431878]
[87]
de Oliveira, J.F.; Lima, T.S.; Vendramini-Costa, D.B.; de Lacerda Pedrosa, S.C.B.; Lafayette, E.A.; da Silva, R.M.F.; de Almeida, S.M.V.; de Moura, R.O.; Ruiz, A.L.T.G.; de Carvalho, J.E.; de Lima, M.D.C.A. Thiosemicarbazones and 4-thiazolidinones indole-based derivatives: Synthesis, evaluation of antiproliferative activity, cell death mechanisms and topoisomerase inhibition assay. Eur. J. Med. Chem., 2017, 136, 305-314.
[http://dx.doi.org/10.1016/j.ejmech.2017.05.023] [PMID: 28505535]
[88]
Abd El-Meguid, E.A.; Ali, M.M. Synthesis of some novel 4-benzothiazol-2-yl-benzoyl-1H-pyrazoles, and evaluation as antiangiogenic agents. Res. Chem. Intermed., 2016, 42(2), 1521-1536.
[http://dx.doi.org/10.1007/s11164-015-2100-8]
[89]
Pahontu, E.; Fala, V.; Gulea, A.; Poirier, D.; Tapcov, V.; Rosu, T. Synthesis and characterization of some new Cu(II), Ni(II) and Zn(II) complexes with salicylidene thiosemicarbazones: Antibacterial, antifungal and in vitro antileukemia activity. Molecules, 2013, 18(8), 8812-8836.
[http://dx.doi.org/10.3390/molecules18088812] [PMID: 23887722]
[90]
Siwek, A. Stączek, P.; Wujec, M.; Bielawski, K.; Bielawska, A.; Paneth, P. Cytotoxic effect and molecular docking of 4-ethoxycarbonylmethyl-1-(piperidin-4-ylcarbonyl)-thiosemicarbazide--a novel topoisomerase II inhibitor. J. Mol. Model., 2013, 19(3), 1319-1324.
[http://dx.doi.org/10.1007/s00894-012-1679-6] [PMID: 23187686]
[91]
He, J.; Wang, X.; Zhao, X.; Liang, Y.; He, H.; Fu, L. Synthesis and antitumor activity of novel quinazoline derivatives containing thiosemicarbazide moiety. Eur. J. Med. Chem., 2012, 54, 925-930.
[http://dx.doi.org/10.1016/j.ejmech.2012.06.003] [PMID: 22749192]
[92]
Dilović I.; Rubcić M.; Vrdoljak, V.; Kraljević Pavelić S.; Kralj, M.; Piantanida, I.; Cindrić M. Novel thiosemicarbazone derivatives as potential antitumor agents: Synthesis, physicochemical and structural properties, DNA interactions and antiproliferative activity. Bioorg. Med. Chem., 2008, 16(9), 5189-5198.
[http://dx.doi.org/10.1016/j.bmc.2008.03.006] [PMID: 18358728]

Rights & Permissions Print Cite
© 2025 Bentham Science Publishers | Privacy Policy
Request history8.2.27PHP Version328msRequest Duration28MBMemory UsageGET article/{article_id}/{param?}Route
  • warninglog[20:58:18] LOG.warning: Optional parameter $article_id declared before required parameter $request i...
  • warninglog[20:58:18] LOG.warning: Function strftime() is deprecated in /home/alphaeurekaselec/public_html/stor...
  • warninglog[20:58:18] LOG.warning: trim(): Passing null to parameter #1 ($string) of type string is deprecated ...
  • warninglog[20:58:18] LOG.warning: Function strftime() is deprecated in /home/alphaeurekaselec/public_html/stor...
  • Booting (117ms)time
  • Application (212ms)time
  • 1 x Application (64.45%)
    212ms
    1 x Booting (35.55%)
    117ms
    14 templates were rendered
    • articlearticle.blade.php#?blade
    • includes.article_top_bannerarticle_top_banner.blade.php#?blade
    • includes.article_referencearticle_reference.blade.php#?blade
    • export_citation_formexport_citation_form.blade.php#?blade
    • includes.article_bottom_bannerarticle_bottom_banner.blade.php#?blade
    • includes.inc_related_journalsinc_related_journals.blade.php#?blade
    • includes.inc_related_ebooksinc_related_ebooks.blade.php#?blade
    • includes.journal_rightmenujournal_rightmenu.blade.php#?blade
    • includes.journal_right_bannerjournal_right_banner.blade.php#?blade
    • layouts.appapp.blade.php#?blade
    • layouts._login_access_login_access.blade.php#?blade
    • layouts._header_header.blade.php#?blade
    • layouts._main_menu_main_menu.blade.php#?blade
    • layouts._footer_menu_footer_menu.blade.php#?blade
    uri
    GET article/{article_id}/{param?}
    middleware
    web, check_user_access
    controller
    App\Http\Controllers\ArticleController@GetArticleDetails
    namespace
    App\Http\Controllers
    where
    as
    article
    file
    app/Http/Controllers/ArticleController.php:1974-2510
    36 statements were executed, 4 of which were duplicates, 32 unique. Show only duplicated124ms
    • Connection Establishedalphaeurekaselec_live_10_06_2022UserAccessCheck.php#24
      Backtrace
      • 9. middleware::check_user_access:24
      • 10. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 11. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 12. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 13. vendor/laravel/framework/src/Illuminate/Foundation/Http/Middleware/VerifyCsrfToken.php:88
    • INSERT INTO visitor_ip_address (ip_address,visitor_agent,visitor_count, created_on,updated_on) VALUES ('59426842','',1,1740776298,1740776298) ON DUPLICATE KEY UPDATE visitor_count=visitor_count + 1, updated_on=1740776298
      990μsalphaeurekaselec_live_10_06_2022UserAccessCheck.php#24
      Backtrace
      • 11. middleware::check_user_access:24
      • 12. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 14. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 15. vendor/laravel/framework/src/Illuminate/Foundation/Http/Middleware/VerifyCsrfToken.php:88
    • INSERT INTO visitor_ip_address_detail (ip_address,visitor_url,visitor_count, created_on,updated_on) VALUES ('59426842','/article/124157',1,1740776298,1740776298)
      200μsalphaeurekaselec_live_10_06_2022UserAccessCheck.php#27
      Backtrace
      • 11. middleware::check_user_access:27
      • 12. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 14. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 15. vendor/laravel/framework/src/Illuminate/Foundation/Http/Middleware/VerifyCsrfToken.php:88
    • (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_journal_volume_trail WHERE to_ip >= 59426842 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59426842) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_journal_volume_corporate WHERE to_ip >= 59426842 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59426842) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_journal_volume_token WHERE to_ip >= 59426842 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59426842) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_ebook_volume_trail WHERE to_ip >= 59426842 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59426842) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_ebook_volume_corporate WHERE to_ip >= 59426842 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59426842) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_ebook_volume_token WHERE to_ip >= 59426842 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59426842) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_issue_trail WHERE to_ip >= 59426842 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59426842) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_issue_corporate WHERE to_ip >= 59426842 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59426842) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_issue_token WHERE to_ip >= 59426842 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59426842) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_article_trail WHERE to_ip >= 59426842 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59426842) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_article_corporate WHERE to_ip >= 59426842 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59426842) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_article_token WHERE to_ip >= 59426842 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59426842) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_chapter_trail WHERE to_ip >= 59426842 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59426842) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_chapter_corporate WHERE to_ip >= 59426842 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59426842) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_chapter_token WHERE to_ip >= 59426842 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59426842) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_disease_corporate WHERE to_ip >= 59426842 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 59426842) limit 1
      13.39msalphaeurekaselec_live_10_06_2022UserAccess.php#784
      Bindings
      • 0: 59426842
      • 1: 59426842
      • 2: 59426842
      • 3: 59426842
      • 4: 59426842
      • 5: 59426842
      • 6: 59426842
      • 7: 59426842
      • 8: 59426842
      • 9: 59426842
      • 10: 59426842
      • 11: 59426842
      • 12: 59426842
      • 13: 59426842
      • 14: 59426842
      • 15: 59426842
      Backtrace
      • 14. app/Models/UserAccess/UserAccess.php:784
      • 15. middleware::check_user_access:114
      • 16. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 18. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
    • SELECT at.type_name, p.copyright, p.publisher_location,m.month,y.year, a.publish_on, a.nid article_nid,a.article_id, a.pmid, a.issue_id, a.title, a.abstract,a.podcast,a.altmetric_score,a.altmetric_url,a.kudos_url, a.page_count, a.first_page, a.elocator, a.last_page, i.publication_date, a.file_name, a.file_path, a.doi, a.is_epub,a.epub_type, a.volume_id, a.is_uploaded, a.editor_choice, a.is_epub, j.image_file_name, a.article_no, a.art_type AS article_type, a.supplementary_filename,a.html_filename,a.prc_filename,a.epub_filename, a.graph_abs_lg_filename, a.graph_abs_sm_filename, a.oa_image_lg_filename, a.oa_image_sm_filename, j.journal_banner,a.animated_abstract,a.erratum_in,a.erratum_for, (CASE WHEN a.issue_id =0 THEN j.epub_price ELSE j.price END) AS sell_price, j.epub_price, j.nid AS jour_nid, j.title AS journal_title, j.issn, j.eissn,j.journal_id, j.subtitle AS jour_subtitle, v.volume_id,v.volume_name AS volume, v.year_id, i.title AS issue, i.month_id ,i.type issue_type, j.subtitle,j.formerly_title, ac.subtitle AS epub_title,a.crossmark_enabled,a.text_mining_urls,a.license_urls,a.created, a.receivedate, a.revisedate, a.acceptdate,js.js_title FROM article a LEFT JOIN article_section ac ON a.is_epub = ac.art_sec_id LEFT JOIN journal_section js ON a.js_id = js.js_id LEFT JOIN article_type at ON a.art_type = at.art_type_id LEFT JOIN issue i ON a.issue_id = i.issue_id LEFT JOIN month m ON m.id = i.month_id LEFT JOIN volume v ON v.volume_id = a.volume_id INNER JOIN year y ON y.id = v.year_id INNER JOIN journal j ON j.journal_id = a.journal_id INNER JOIN publisher p ON p.publisher_id = j.publisher_id WHERE a.article_id=124157
      770μsalphaeurekaselec_live_10_06_2022Article.php#408
      Backtrace
      • 11. app/Models/Article.php:408
      • 12. app/Http/Controllers/ArticleController.php:2515
      • 13. app/Http/Controllers/ArticleController.php:2035
      • 14. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 15. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select * from `journal` where `journal_id` = 1 limit 1
      1.09msalphaeurekaselec_live_10_06_2022Journal.php#64
      Bindings
      • 0: 1
      Backtrace
      • 14. app/Models/Journal.php:64
      • 15. app/Http/Controllers/ArticleController.php:2516
      • 16. app/Http/Controllers/ArticleController.php:2035
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select count(*) as aggregate from (select j.nid as journal_nid,j.flyer_link,j.title ,j.issn,j.eissn,j.keyword, j.journal_id as journal_id, j.subtitle, j.image_file_name,j.description,j.journal_insight_url,j.doi from `subject_journal` as `sj` inner join `journal` as `j` on `j`.`journal_id` = `sj`.`journal_id` where j.journal_status=1 and subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=1) and sj.journal_id!=1 group by `j`.`nid`) as `aggregate_table`
      1.28msalphaeurekaselec_live_10_06_2022Subject.php#200
      Backtrace
      • 16. app/Models/Subject.php:200
      • 17. app/Http/Controllers/ArticleController.php:2517
      • 18. app/Http/Controllers/ArticleController.php:2035
      • 19. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 20. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select j.nid as journal_nid,j.flyer_link,j.title ,j.issn,j.eissn,j.keyword, j.journal_id as journal_id, j.subtitle, j.image_file_name,j.description,j.journal_insight_url,j.doi from `subject_journal` as `sj` inner join `journal` as `j` on `j`.`journal_id` = `sj`.`journal_id` where j.journal_status=1 and subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=1) and sj.journal_id!=1 group by `j`.`nid` order by `j`.`journal_id` asc limit 10 offset 0
      1.04msalphaeurekaselec_live_10_06_2022Subject.php#200
      Backtrace
      • 14. app/Models/Subject.php:200
      • 15. app/Http/Controllers/ArticleController.php:2517
      • 16. app/Http/Controllers/ArticleController.php:2035
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select count(*) as aggregate from (select v.nid as volume_id,e.nid,e.title,v.issn,v.eissn,v.isbn,v.eisbn,e.ebook_id, v.image_file_name,v.file_path,v.flyer_link,v.ebook_volume_id, v.volume_name,v.doi,v.year_id,v.introduction from `subject_ebook` as `se` inner join `ebook` as `e` on `e`.`ebook_id` = `se`.`ebook_id` inner join `ebook_volume` as `v` on `v`.`ebook_id` = `se`.`ebook_id` inner join `year` as `y` on `y`.`id` = `v`.`year_id` where subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=1) and v.ebook_status='1' and y.year > 2020 group by `v`.`nid`) as `aggregate_table`
      3.17msalphaeurekaselec_live_10_06_2022Subject.php#220
      Backtrace
      • 16. app/Models/Subject.php:220
      • 17. app/Http/Controllers/ArticleController.php:2518
      • 18. app/Http/Controllers/ArticleController.php:2035
      • 19. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 20. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select v.nid as volume_id,e.nid,e.title,v.issn,v.eissn,v.isbn,v.eisbn,e.ebook_id, v.image_file_name,v.file_path,v.flyer_link,v.ebook_volume_id, v.volume_name,v.doi,v.year_id,v.introduction from `subject_ebook` as `se` inner join `ebook` as `e` on `e`.`ebook_id` = `se`.`ebook_id` inner join `ebook_volume` as `v` on `v`.`ebook_id` = `se`.`ebook_id` inner join `year` as `y` on `y`.`id` = `v`.`year_id` where subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=1) and v.ebook_status='1' and y.year > 2020 group by `v`.`nid` order by `v`.`ebook_volume_id` desc limit 10 offset 0
      2.66msalphaeurekaselec_live_10_06_2022Subject.php#220
      Backtrace
      • 14. app/Models/Subject.php:220
      • 15. app/Http/Controllers/ArticleController.php:2518
      • 16. app/Http/Controllers/ArticleController.php:2035
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select * from `keywords` where `article_id` = '124157'
      1.35msalphaeurekaselec_live_10_06_2022Keywords.php#43
      Bindings
      • 0: 124157
      Backtrace
      • 13. app/Models/Keywords.php:43
      • 14. app/Http/Controllers/ArticleController.php:2519
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select * from `article_citation` where `article_id` = '124157'
      7.21msalphaeurekaselec_live_10_06_2022Article.php#1570
      Bindings
      • 0: 124157
      Backtrace
      • 13. app/Models/Article.php:1570
      • 14. app/Http/Controllers/ArticleController.php:2520
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select CONCAT_WS(' ',au.first_name, ' ', ifnull(au.initials,''), ' ', au.last_name) as authors, CONCAT(au.last_name, IFNULL(CONCAT(' ', au.initials), ''), ' ', au.first_name) AS authorsRIS, CONCAT_WS(' ',au.last_name, ' ', ifnull(au.initials,''), ' ', au.first_name) as authorsCiteAs, CONCAT_WS(' ',au.first_name, IFNULL(CONCAT(' ', au.initials), ''), IFNULL(CONCAT(' ', au.last_name), '')) as authorsmodal , `au`.*, `af`.`ror_id`, `af`.`institution`, `af`.`department`, `af`.`country`, `af`.`city`, `af`.`address`, (GROUP_CONCAT(TRIM(BOTH ', ' FROM CONCAT(ifnull(concat(af.institution,','),''), ifnull(concat(af.department,','),''), ifnull(concat(af.address,','),''), ifnull(concat(af.city,','),''), ifnull(concat(af.country,','),''), ifnull(concat(af.postal_code,','),''), ifnull(concat(af.phone,','),''), ifnull(concat(af.fax,','),''))) SEPARATOR '|')) as `author_affiliation`, (GROUP_CONCAT(TRIM(BOTH ', ' FROM CONCAT(ifnull(concat(af.web_view,','),''))) SEPARATOR '|')) as `web_view` from `author` as `au` left join `author_affiliation` as `af` on `au`.`author_id` = `af`.`author_id` where `au`.`article_id` = '124157' group by `au`.`author_id` order by `au`.`article_id` asc, `au`.`sequence` asc
      3.28msalphaeurekaselec_live_10_06_2022Author.php#86
      Bindings
      • 0: 124157
      Backtrace
      • 13. app/Models/Author.php:86
      • 14. app/Http/Controllers/ArticleController.php:2533
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select `bo`.* from `bundle_offer` as `bo` where `bo`.`bundle_status` = 'A' order by `bo`.`bundle_id` desc
      280μsalphaeurekaselec_live_10_06_2022BundleOffer.php#57
      Bindings
      • 0: A
      Backtrace
      • 13. app/Models/BundleOffer.php:57
      • 14. app/Http/Controllers/ArticleController.php:2535
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select `subtitle` from `journal` where `continues_publication_journal` = 1
      510μsalphaeurekaselec_live_10_06_2022Article.php#1960
      Bindings
      • 0: 1
      Backtrace
      • 13. app/Models/Article.php:1960
      • 14. app/Http/Controllers/ArticleController.php:2062
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • Select j.subtitle, v.volume_id as volume_id,v.year_id,y.year as year,v.volume_name, v.total_no_of_issues, i.issue_id as issue_id,i.title as issue, i.publication_date as issue_pub_date from journal j join volume v on j.journal_id = v.journal_id join issue i on v.volume_id = i.volume_id join article a on a.issue_id = i.issue_id join year y on v.year_id = y.id where j.journal_id = 1 and i.is_uploaded = 1 order by v.volume_name+0 desc, i.title+0 desc limit 1
      26.26msalphaeurekaselec_live_10_06_2022Issue.php#298
      Backtrace
      • 11. app/Models/Issue.php:298
      • 12. app/Http/Controllers/ArticleController.php:2068
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select a.nid,a.publish_on, a.pmid,a.article_id,a.doi,j.journal_id,j.subtitle,v.volume_name,a.volume_id as volume_id, a.issue_id,a.title,first_page, last_page, page_count,abstract,ifnull(is_abstract,"y"),asec.title as article_section,at.type_name as article_type_name, a.article_id as ArticleID ,is_epub,epub_price,epub_type,a.created, y.year from `article` as `a` left join `article_section` as `asec` on `asec`.`art_sec_id` = `a`.`is_epub` left join `article_type` as `at` on `at`.`art_type_id` = `a`.`art_type` left join `journal` as `j` on `j`.`journal_id` = `a`.`journal_id` inner join `volume` as `v` on `a`.`volume_id` = `v`.`volume_id` inner join `year` as `y` on `v`.`year_id` = `y`.`id` where a.article_status != "W" and a.is_epub = 1 and a.journal_id = 1 and a.is_uploaded = 1 group by `a`.`article_id` order by `a`.`publish_on` desc
      16msalphaeurekaselec_live_10_06_2022Article.php#528
      Backtrace
      • 13. app/Models/Article.php:528
      • 14. app/Http/Controllers/ArticleController.php:2070
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select a.nid,a.publish_on, a.pmid,a.article_id,a.doi,j.journal_id,j.subtitle,v.volume_name,a.volume_id as volume_id, a.issue_id,a.title,first_page, last_page, page_count,abstract,ifnull(is_abstract,"y"),asec.title as article_section,at.type_name as article_type_name, a.article_id as ArticleID ,is_epub,epub_price,epub_type,a.created, y.year from `article` as `a` left join `article_section` as `asec` on `asec`.`art_sec_id` = `a`.`is_epub` left join `article_type` as `at` on `at`.`art_type_id` = `a`.`art_type` left join `journal` as `j` on `j`.`journal_id` = `a`.`journal_id` inner join `volume` as `v` on `a`.`volume_id` = `v`.`volume_id` inner join `year` as `y` on `v`.`year_id` = `y`.`id` where a.article_status != "W" and a.is_epub = 4 and a.journal_id = 1 and a.is_uploaded = 1 group by `a`.`article_id` order by `a`.`publish_on` desc
      17.43msalphaeurekaselec_live_10_06_2022Article.php#528
      Backtrace
      • 13. app/Models/Article.php:528
      • 14. app/Http/Controllers/ArticleController.php:2071
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select pdf, html, epub, prc from `article_metrics` where `article_id` = 124157 limit 1
      350μsalphaeurekaselec_live_10_06_2022Article.php#744
      Bindings
      • 0: 124157
      Backtrace
      • 14. app/Models/Article.php:744
      • 15. app/Http/Controllers/ArticleController.php:2091
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from content_by_diseases where content_id = 124157 and content_type = 'article' order by status desc limit 1
      310μsalphaeurekaselec_live_10_06_2022Article.php#751
      Backtrace
      • 11. app/Models/Article.php:751
      • 12. app/Http/Controllers/ArticleController.php:2094
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `node_meta` where `nid` = 205581 limit 1
      240μsalphaeurekaselec_live_10_06_2022Meta.php#30
      Bindings
      • 0: 205581
      Backtrace
      • 14. app/Models/Meta.php:30
      • 15. app/Http/Controllers/ArticleController.php:2101
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select `bo`.* from `bundle_offer` as `bo` where `bo`.`bundle_status` = 'A' order by `bo`.`bundle_id` desc
      280μsalphaeurekaselec_live_10_06_2022BundleOffer.php#57
      Bindings
      • 0: A
      Backtrace
      • 13. app/Models/BundleOffer.php:57
      • 14. app/Http/Controllers/ArticleController.php:2108
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `tbl_ht_submission` as `h` where `h`.`subtitle` = 'ACAMC' and (h.proposal_closing_date = 0 OR TO_DAYS(FROM_UNIXTIME(h.proposal_closing_date)) >= TO_DAYS(NOW())) order by `h`.`manuscript` asc
      360μsalphaeurekaselec_live_10_06_2022Article.php#2025
      Bindings
      • 0: ACAMC
      Backtrace
      • 13. app/Models/Article.php:2025
      • 14. app/Http/Controllers/ArticleController.php:2112
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select count(*) as total_count, content_type_access_id as access_type from journal_access where content_type_id = '124157' and content_type = 'a' and ( (from_date <= CURDATE() and to_date >= CURDATE() and perpetual= 0) or (from_date is null and to_date is null and perpetual= 1) )
      500μsalphaeurekaselec_live_10_06_2022ContentAccess.php#647
      Backtrace
      • 11. app/Models/ContentAccess.php:647
      • 12. app/Http/Controllers/ArticleController.php:2186
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select count(*) as total_count, content_type_access_id as access_type from journal_access where content_type_id = '12012' and content_type = 'i' and ( (from_date <= CURDATE() and to_date >= CURDATE() and perpetual= 0) or (from_date is null and to_date is null and perpetual= 1) )
      460μsalphaeurekaselec_live_10_06_2022ContentAccess.php#647
      Backtrace
      • 11. app/Models/ContentAccess.php:647
      • 12. app/Http/Controllers/ArticleController.php:2207
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select count(*) as total_count, content_type_access_id as access_type from journal_access where content_type_id = '3314' and content_type = 'v' and ( (from_date <= CURDATE() and to_date >= CURDATE() and perpetual= 0) or (from_date is null and to_date is null and perpetual= 1) )
      440μsalphaeurekaselec_live_10_06_2022ContentAccess.php#647
      Backtrace
      • 11. app/Models/ContentAccess.php:647
      • 12. app/Http/Controllers/ArticleController.php:2231
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Trial Access" as access_base_text, CASE j.type WHEN 111 THEN true ELSE false END as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"volume" as access_level,"" as issue_id,"" as article_id from `user_access_journal_volume_trail` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 59426842 and j.to_ip >=59426842 )) and ((j.from_date <= 1740776298 and j.to_date >= 1740776298 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.volume_id = 3314) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Subscribed" as access_base_text, false as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"volume" as access_level,"" as issue_id,"" as article_id from `user_access_journal_volume_corporate` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 59426842 and j.to_ip >=59426842 )) and ((j.from_date <= 1740776298 and j.to_date >= 1740776298 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.volume_id = 3314) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Token Based Access" as access_base_text, false as terms_popup, "R" as content_download_type, j.uc_id as restricted_user_access_key, "v" as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"volume" as access_level,"" as issue_id,"" as article_id from `user_access_journal_volume_token` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 59426842 and j.to_ip >=59426842 )) and ((j.from_date <= 1740776298 and j.to_date >= 1740776298 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.volume_id = 3314)
      15.81msalphaeurekaselec_live_10_06_2022UserAccess.php#1266
      Backtrace
      • 13. app/Models/UserAccess/UserAccess.php:1266
      • 14. app/Http/Controllers/ArticleController.php:2272
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Trial Access" as access_base_text, CASE j.type WHEN 111 THEN true ELSE false END as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"issue" as access_level,j.issue_id,"" as article_id from `user_access_issue_trail` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 59426842 and j.to_ip >=59426842 )) and ((j.from_date <= 1740776298 and j.to_date >= 1740776298 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.issue_id = 12012) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Subscribed" as access_base_text, false as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"issue" as access_level,j.issue_id,"" as article_id from `user_access_issue_corporate` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 59426842 and j.to_ip >=59426842 )) and ((j.from_date <= 1740776298 and j.to_date >= 1740776298 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.issue_id = 12012) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Token Based Access" as access_base_text, false as terms_popup, "R" as content_download_type, j.uc_id as restricted_user_access_key, "v" as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"issue" as access_level,j.issue_id,"" as article_id from `user_access_issue_token` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 59426842 and j.to_ip >=59426842 )) and ((j.from_date <= 1740776298 and j.to_date >= 1740776298 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.issue_id = 12012)
      950μsalphaeurekaselec_live_10_06_2022UserAccess.php#1266
      Backtrace
      • 13. app/Models/UserAccess/UserAccess.php:1266
      • 14. app/Http/Controllers/ArticleController.php:2297
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Trial Access" as access_base_text, CASE j.type WHEN 111 THEN true ELSE false END as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"article" as access_level, j.issue_id, j.article_id from `user_access_article_trail` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 59426842 and j.to_ip >=59426842 )) and ((j.from_date <= 1740776298 and j.to_date >= 1740776298 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.article_id = 124157) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Subscribed" as access_base_text, false as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"article" as access_level, j.issue_id, j.article_id from `user_access_article_corporate` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 59426842 and j.to_ip >=59426842 )) and ((j.from_date <= 1740776298 and j.to_date >= 1740776298 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.article_id = 124157) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Token Based Access" as access_base_text, false as terms_popup, "R" as content_download_type, j.uc_id as restricted_user_access_key, "v" as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"article" as access_level, j.issue_id, j.article_id from `user_access_article_token` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 59426842 and j.to_ip >=59426842 )) and ((j.from_date <= 1740776298 and j.to_date >= 1740776298 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.article_id = 124157)
      620μsalphaeurekaselec_live_10_06_2022UserAccess.php#1266
      Backtrace
      • 13. app/Models/UserAccess/UserAccess.php:1266
      • 14. app/Http/Controllers/ArticleController.php:2329
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `article` where `first_page` < '60' and is_uploaded = 1 and issue_id = 12012 order by cast(first_page as SIGNED) desc limit 1
      520μsalphaeurekaselec_live_10_06_2022Article.php#1819
      Bindings
      • 0: 60
      Backtrace
      • 14. app/Models/Article.php:1819
      • 15. app/Http/Controllers/ArticleController.php:2470
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `article` where `last_page` > '75' and is_uploaded = 1 and issue_id = 12012 order by cast(first_page as SIGNED) asc limit 1
      420μsalphaeurekaselec_live_10_06_2022Article.php#1831
      Bindings
      • 0: 75
      Backtrace
      • 14. app/Models/Article.php:1831
      • 15. app/Http/Controllers/ArticleController.php:2472
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select `language_id` from `multilanguage` where `short_code` = 'en'
      200μsalphaeurekaselec_live_10_06_2022ArticleController.php#2497
      Bindings
      • 0: en
      Backtrace
      • 14. app/Http/Controllers/ArticleController.php:2497
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:206
    • select `source_lang_label`, `target_lang_label` from `multilanguage_labels` where `target_lang_id` = 1
      190μsalphaeurekaselec_live_10_06_2022MultiLanguage.php#23
      Bindings
      • 0: 1
      Backtrace
      • 13. app/Models/MultiLanguage.php:23
      • 14. app/Http/Controllers/ArticleController.php:2498
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select `id` from `multilanguage_article` where `article_id` = 124157 limit 1
      2.51msalphaeurekaselec_live_10_06_2022ArticleController.php#2506
      Bindings
      • 0: 124157
      Backtrace
      • 16. app/Http/Controllers/ArticleController.php:2506
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 19. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
      • 20. vendor/laravel/framework/src/Illuminate/Routing/Route.php:206
    • select b.banner_link, b.banner_name, b.banner_script, b.banner_remarks, b.banner_file_name, b.banner_placement, bd.content_type, bd.content_id from `tbl_banner` as `b` inner join `tbl_banner_detail` as `bd` on `bd`.`banner_id` = `b`.`banner_id` inner join `users` as `u` on `u`.`id` = `b`.`updated_by` inner join `journal` as `j` on `j`.`journal_id` = `bd`.`content_id` where `b`.`banner_journal` = 1 and `bd`.`content_type` = 'J' and `bd`.`content_id` = 1 and `b`.`banner_from_date` <= 1740776298 and `b`.`banner_to_date` >= 1740776298 and `b`.`banner_status` = 'A' order by `b`.`banner_id` desc
      1.25msalphaeurekaselec_live_10_06_2022Banner.php#95
      Bindings
      • 0: 1
      • 1: J
      • 2: 1
      • 3: 1740776298
      • 4: 1740776298
      • 5: A
      Backtrace
      • 13. app/Models/Banner.php:95
      • 14. app/Http/helpers.php:404
      • 17. vendor/laravel/framework/src/Illuminate/Filesystem/Filesystem.php:124
      • 18. vendor/laravel/framework/src/Illuminate/View/Engines/PhpEngine.php:58
      • 19. vendor/laravel/framework/src/Illuminate/View/Engines/CompilerEngine.php:73
    • select b.banner_link, b.banner_name, b.banner_script, b.banner_remarks, b.banner_file_name, b.banner_placement, bd.content_type, bd.content_id from `tbl_banner` as `b` inner join `tbl_banner_detail` as `bd` on `bd`.`banner_id` = `b`.`banner_id` inner join `users` as `u` on `u`.`id` = `b`.`updated_by` inner join `journal` as `j` on `j`.`journal_id` = `bd`.`content_id` where `b`.`banner_journal` = 1 and `bd`.`content_type` = 'J' and `bd`.`content_id` = 1 and `b`.`banner_from_date` <= 1740776298 and `b`.`banner_to_date` >= 1740776298 and `b`.`banner_status` = 'A' order by `b`.`banner_id` desc
      1.18msalphaeurekaselec_live_10_06_2022Banner.php#95
      Bindings
      • 0: 1
      • 1: J
      • 2: 1
      • 3: 1740776298
      • 4: 1740776298
      • 5: A
      Backtrace
      • 13. app/Models/Banner.php:95
      • 14. app/Http/helpers.php:404
      • 17. vendor/laravel/framework/src/Illuminate/Filesystem/Filesystem.php:124
      • 18. vendor/laravel/framework/src/Illuminate/View/Engines/PhpEngine.php:58
      • 19. vendor/laravel/framework/src/Illuminate/View/Engines/CompilerEngine.php:73
    • select count(*) as aggregate from `uc_cart_products` where cart_id='6cd494dd7aacf6e97749a57f8ef54869'
      290μsalphaeurekaselec_live_10_06_2022Cart.php#271
      Backtrace
      • 15. app/Models/Cart.php:271
      • 16. view::layouts._header:291
      • 18. vendor/laravel/framework/src/Illuminate/Filesystem/Filesystem.php:124
      • 19. vendor/laravel/framework/src/Illuminate/View/Engines/PhpEngine.php:58
      • 20. vendor/laravel/framework/src/Illuminate/View/Engines/CompilerEngine.php:73
    App\Models\MultiLanguage
    1MultiLanguage.php#?
        _token
        qg2KoYCmejYg4IgWg3QQ9IzmUmGyYCxuSzOdW5CY
        uc_cart_id
        6cd494dd7aacf6e97749a57f8ef54869
        _previous
        array:1 [ "url" => "https://alpha.eurekaselect.com/article/124157" ]
        _flash
        array:2 [ "old" => [] "new" => [] ]
        PHPDEBUGBAR_STACK_DATA
        []
        path_info
        /article/124157
        status_code
        200
        
        status_text
        OK
        format
        html
        content_type
        text/html; charset=UTF-8
        request_query
        []
        
        request_request
        []
        
        request_headers
        0 of 0
        array:16 [ "x-https" => array:1 [ 0 => "1" ] "host" => array:1 [ 0 => "alpha.eurekaselect.com" ] "priority" => array:1 [ 0 => "u=0, i" ] "accept-encoding" => array:1 [ 0 => "gzip, deflate, br, zstd" ] "sec-fetch-dest" => array:1 [ 0 => "document" ] "sec-fetch-user" => array:1 [ 0 => "?1" ] "sec-fetch-mode" => array:1 [ 0 => "navigate" ] "sec-fetch-site" => array:1 [ 0 => "none" ] "accept" => array:1 [ 0 => "text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.7" ] "user-agent" => array:1 [ 0 => "Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)" ] "upgrade-insecure-requests" => array:1 [ 0 => "1" ] "sec-ch-ua-platform" => array:1 [ 0 => ""Windows"" ] "sec-ch-ua-mobile" => array:1 [ 0 => "?0" ] "sec-ch-ua" => array:1 [ 0 => ""HeadlessChrome";v="129", "Not=A?Brand";v="8", "Chromium";v="129"" ] "cache-control" => array:1 [ 0 => "no-cache" ] "pragma" => array:1 [ 0 => "no-cache" ] ]
        request_cookies
        []
        
        response_headers
        0 of 0
        array:5 [ "content-type" => array:1 [ 0 => "text/html; charset=UTF-8" ] "cache-control" => array:1 [ 0 => "no-cache, private" ] "date" => array:1 [ 0 => "Fri, 28 Feb 2025 20:58:18 GMT" ] "set-cookie" => array:2 [ 0 => "XSRF-TOKEN=eyJpdiI6ImdDTHY2dFNwa285ck9aRm9nb3FqVmc9PSIsInZhbHVlIjoieEVCb3RJMnFSRzZHR0Zqc1RXNzNuNEFLTkFFWk1Rbk1sL1lhUHJ1V2RPaThmMit3NjlzSjQwelExa0t5bGErVHZrRlRobjFUcDhLZjNVVEpmS1I1ZmtGTWtFRGhJSG5UbU4vakVoVXB6eWs3STF6YU54VjZhdzlxQ0hWcG1jWFoiLCJtYWMiOiJkNDZmODUwZTlmOGI5MjU1MGYyMjM4MTZmOWM3ZWE4YzZiNzY4MTFlMWExNjdlOTI4YWUxYmZiZGQ5ODBjYTBmIiwidGFnIjoiIn0%3D; expires=Mon, 03 Mar 2025 08:58:18 GMT; Max-Age=216000; path=/; secure; samesite=laxXSRF-TOKEN=eyJpdiI6ImdDTHY2dFNwa285ck9aRm9nb3FqVmc9PSIsInZhbHVlIjoieEVCb3RJMnFSRzZHR0Zqc1RXNzNuNEFLTkFFWk1Rbk1sL1lhUHJ1V2RPaThmMit3NjlzSjQwelExa0t5bGErVHZrRlRob" 1 => "alphaeurekaselectnet_session=eyJpdiI6ImpFdVdMYjF5dThxalA1Y1dCZFlsN0E9PSIsInZhbHVlIjoiUVFSRlQyK0ZBZFJuY2NKdnRnM002U3hNcndJNktVdFBqQzdMN3M3UzRKWUFnbVFqLzkvcU53UmFYYlFxeHo2NU1iUzEzeEtuRWZyb2N0UlNFckNFaUtDa0lNS3ZTcWRGWUdIZVl1cFkrenJ2ZVhnSUkwbTBVOFRHZ3A2MkQ0cGQiLCJtYWMiOiI2NmUyNmQ3MjVkZTYzM2FjNDI3ODY5Nzc0ZWMyNDg4NmNiNDExNTVlMDQ5NGI2ZGNlZjU0ZDk5ZmYzM2FlOTQ0IiwidGFnIjoiIn0%3D; path=/; secure; httponly; samesite=laxalphaeurekaselectnet_session=eyJpdiI6ImpFdVdMYjF5dThxalA1Y1dCZFlsN0E9PSIsInZhbHVlIjoiUVFSRlQyK0ZBZFJuY2NKdnRnM002U3hNcndJNktVdFBqQzdMN3M3UzRKWUFnbVFqLzkvcU53UmF" ] "Set-Cookie" => array:2 [ 0 => "XSRF-TOKEN=eyJpdiI6ImdDTHY2dFNwa285ck9aRm9nb3FqVmc9PSIsInZhbHVlIjoieEVCb3RJMnFSRzZHR0Zqc1RXNzNuNEFLTkFFWk1Rbk1sL1lhUHJ1V2RPaThmMit3NjlzSjQwelExa0t5bGErVHZrRlRobjFUcDhLZjNVVEpmS1I1ZmtGTWtFRGhJSG5UbU4vakVoVXB6eWs3STF6YU54VjZhdzlxQ0hWcG1jWFoiLCJtYWMiOiJkNDZmODUwZTlmOGI5MjU1MGYyMjM4MTZmOWM3ZWE4YzZiNzY4MTFlMWExNjdlOTI4YWUxYmZiZGQ5ODBjYTBmIiwidGFnIjoiIn0%3D; expires=Mon, 03-Mar-2025 08:58:18 GMT; path=/; secureXSRF-TOKEN=eyJpdiI6ImdDTHY2dFNwa285ck9aRm9nb3FqVmc9PSIsInZhbHVlIjoieEVCb3RJMnFSRzZHR0Zqc1RXNzNuNEFLTkFFWk1Rbk1sL1lhUHJ1V2RPaThmMit3NjlzSjQwelExa0t5bGErVHZrRlRob" 1 => "alphaeurekaselectnet_session=eyJpdiI6ImpFdVdMYjF5dThxalA1Y1dCZFlsN0E9PSIsInZhbHVlIjoiUVFSRlQyK0ZBZFJuY2NKdnRnM002U3hNcndJNktVdFBqQzdMN3M3UzRKWUFnbVFqLzkvcU53UmFYYlFxeHo2NU1iUzEzeEtuRWZyb2N0UlNFckNFaUtDa0lNS3ZTcWRGWUdIZVl1cFkrenJ2ZVhnSUkwbTBVOFRHZ3A2MkQ0cGQiLCJtYWMiOiI2NmUyNmQ3MjVkZTYzM2FjNDI3ODY5Nzc0ZWMyNDg4NmNiNDExNTVlMDQ5NGI2ZGNlZjU0ZDk5ZmYzM2FlOTQ0IiwidGFnIjoiIn0%3D; path=/; secure; httponlyalphaeurekaselectnet_session=eyJpdiI6ImpFdVdMYjF5dThxalA1Y1dCZFlsN0E9PSIsInZhbHVlIjoiUVFSRlQyK0ZBZFJuY2NKdnRnM002U3hNcndJNktVdFBqQzdMN3M3UzRKWUFnbVFqLzkvcU53UmF" ] ]
        session_attributes
        0 of 0
        array:5 [ "_token" => "qg2KoYCmejYg4IgWg3QQ9IzmUmGyYCxuSzOdW5CY" "uc_cart_id" => "6cd494dd7aacf6e97749a57f8ef54869" "_previous" => array:1 [ "url" => "https://alpha.eurekaselect.com/article/124157" ] "_flash" => array:2 [ "old" => [] "new" => [] ] "PHPDEBUGBAR_STACK_DATA" => [] ]
        ClearShow all
        Date ↕MethodURLData
        #12025-02-28 20:58:18GET/article/124157414361